Skip to main content
Equibles
STE logo

STE · STERIS plc · Metrics

Track STE — free

Use STE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research STE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$253.44 -2.83 (-1.10%) At close · Nov 12 Play latest call Q1 2027 earnings call transcript
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$24.61B
Shares
97.11M
Volume · Nov 12 517.64K Avg daily vol (3M) 707.12K

STE metrics

123 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$253.44
Market cap
$24.61B

Price action

23 metrics
Price change (1W)
+3.4%
Price change (30D)
+17.7%
Price change (3M)
+8.3%
Price change (6M)
+21.4%
Price change (YTD)
+1.1%
Price change (1Y)
-3.9%
Trailing year
Price change (5Y)
+10.7%
52-week high
$268.65
52-week low
$199.40
Change from 52-week high
-4.6%
Change from 52-week low
+28.5%
Annualized volatility
26.4%
Annualized volatility (3M)
25.8%
Implied volatility (30D)
25.9%
IV rank (1Y)
27.1
IV percentile (1Y)
53.2
Beta
0.4
RSI (14D)
74.1
Price vs SMA 50
+15.4%
Price vs SMA 200
+14.3%
Avg volume (3M)
709,130
Relative volume
0.8
Average dollar volume
$160.47M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
97.11M

Valuation

12 metrics
P / E (TTM)
32.3
Trailing earnings · reciprocal yield 3.1%
PEG ratio
0.6
EV / revenue
4.3×
reciprocal yield 23.5%
EV / EBITDA
15.8×
reciprocal yield 6.3%
EV / EBIT
22.4×
reciprocal yield 4.5%
P / sales
4.0×
reciprocal yield 24.8%
P / book
3.4
reciprocal yield 29.2%
FCF yield
3.8%
TTM · current market cap
Buyback yield
1.4%
P / FCF
26.6
reciprocal yield 3.8%
P / operating cash flow
19.3
reciprocal yield 5.2%
Earnings yield
3.3%

Historical valuation

8 metrics
P / E historical average (3Y)
40.7×
reciprocal yield 2.5%
P / E historical average (5Y)
57.3×
reciprocal yield 1.7%
EV / revenue historical average (3Y)
4.5×
reciprocal yield 22.2%
EV / revenue historical average (5Y)
4.8×
reciprocal yield 20.8%
EV / EBIT historical average (3Y)
27.3×
reciprocal yield 3.7%
EV / EBIT historical average (5Y)
51.5×
reciprocal yield 1.9%
EV / EBITDA historical average (3Y)
17.4×
reciprocal yield 5.7%
EV / EBITDA historical average (5Y)
21.6×
reciprocal yield 4.6%

Dividends & buybacks

7 metrics
Dividend yield
1.0%
Trailing 12 months
Payout ratio
30.5%
Shareholder yield
2.4%
Dividend / share (TTM)
$2.58
Dividend growth YoY
+10.3%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-04

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-05

Profitability

9 metrics
Gross margin
44.6%
Operating margin
19.0%
Trailing 12 months
Net margin
13.4%
Gross profit (TTM)
$2.75B
Operating profit (TTM)
$1.17B
Net income (TTM)
$826.80M
Trailing 12 months
Diluted EPS (TTM)
$7.93
FCF margin
15.2%
Effective tax rate
26.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$62.81
Gross profit per diluted share (TTM)
$27.99
Operating profit per diluted share (TTM)
$11.92
EBITDA per diluted share (TTM)
$16.96
Net income per diluted share (TTM)
$8.42
Operating cash flow per diluted share (TTM)
$13.14
Free cash flow per diluted share (TTM)
$9.55
Capital expenditures per diluted share (TTM)
$3.59
R&D per diluted share (TTM)
$1.21
Stock compensation per diluted share (TTM)
$0.64
Book value per share
$73.45

Growth

11 metrics
Revenue growth YoY
+8.8%
Year over year
Net income growth YoY
+11.4%
Revenue (TTM)
$6.17B
Trailing 12 months
EPS growth YoY
+51.4%
Shares change YoY
-1.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+9.4%
Revenue CAGR (5Y)
+13.8%
EPS CAGR (3Y)
+95.0%
EPS CAGR (5Y)
+11.4%
FCF CAGR (3Y)
+35.0%
FCF CAGR (5Y)
+16.6%

Quality

14 metrics
Return on equity
11.4%
Return on assets
7.7%
Debt / equity
0.3
Current ratio
2.1
EBITDA (TTM)
$1.66B
Free cash flow (TTM)
$937.20M
Quick ratio
1.4
Interest coverage
20.6
Net debt / EBITDA
0.8
Return on invested capital
10.0%
Trailing 12 months
Net cash
−$1.36B
Latest balance sheet
Cash & equivalents
$531.10M
Total assets
$10.71B
Total debt
$1.89B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.29B
Capital expenditures (TTM)
$352.50M
R&D (TTM)
$118.40M
SG&A (TTM)
$1.44B
Stock compensation (TTM)
$63.10M
R&D / revenue
1.9%
Stock compensation / revenue
1.0%

Ownership (13F)

9 metrics
13F filers
839
13F filer change QoQ
-8
Institutional ownership
97.7%
Conviction holders (share of 13F filers)
0.6%
Crowding (high-turnover and private-fund holders)
23.8%
Private-fund adviser ownership
22.5%
Active holders' share change QoQ
+1.7%
Holder tenure
16.4
Price vs estimated holder cost
-5.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
14.7%

Short interest

3 metrics
Short interest
2.2%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$2.74M
Insider-sentiment score
27 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1757898 CUSIP G8473T100 13F (30d) 588 filings 551 filers Visit website Investor relations